Jagged-1 mutation is associated with congenital heart defects: a case report Authors: Othman Alahmed, Manal Alaamery, Fahad Alhabshan, Farah Chaikhouni, Mohamed S. Kabbani, Patrice Bouvagnet, Salam Massadeh Published: 2026 ABSTRACT BackgroundCongenital heart defects (CHD) refer to a wide range of heart structural abnormalities that exist at birth, ranging from malformations with a good prognosis to more complicated and severe lesions. Congenital heart defects can result from mutations in genes encoding cell signaling transducers such as Jagged-1 (JAG1). Mutations in JAG1 are linked to rare autosomal-dominant disorders, often resulting from haploinsufficiency in the Notch signaling pathway, which affects organ development. Reporting novel mutations and associated phenotypes emphasizes the importance of tailored approaches based on individual phenotypic and genotypic profiles. Next-generation sequencing techniques facilitate the detection of disease-associated mutations, enabling the development of personalized management strategies.Case presentationHere, we present a case of a Saudi Arabian female child who was born extremely preterm. She required intubation and mechanical ventilation immediately after birth. She developed bronchopulmonary dysplasia and pulmonary hypertension. At 8 months old, her echocardiogram revealed a large atrial septal defect and a patent ductus arteriosus. She underwent successful patent ductus arteriosus closure. She exhibited severe failure to thrive and was frequently admitted for respiratory infections. Tragically, she passed away at 11 years of age due to pneumonia and pulmonary hypertensive crises. Exome sequencing of the proband, her parents, and her brother identified a previously undescribed likely pathogenic heterozygous missense variant (c.1127A>G) in the JAG1 gene, inherited from her presumed healthy mother, that is associated with an isolated cardiac phenotype.ConclusionAlthough JAG1 mutations typically manifest as Alagille syndrome, this case underscores their phenotypic variability, specifically presenting as an isolated congenital heart defect. The clinical course demonstrates that pulmonary hypertension is a severe complication of an atrial septal defect (ASD), where persistent left-to-right shunting triggers irreversible vascular remodeling and terminal right heart failure. Ultimately, this report confirms the incomplete penetrance characteristic of JAG1 variants and suggests that extreme prematurity may function as a significant epigenetic or environmental modifier. Introduction Congenital heart defects (CHD) refer to a wide range of heart structural abnormalities that exist at birth, ranging from malformations with a good prognosis to more complicated and severe lesions [1]. These defects often necessitate comprehensive diagnostic analysis as early as possible to provide specialized care tailored to the individual’s unique anatomical and physiological characteristics [2]. In a retrospective study, it was shown that early diagnosis has helped to reduce the mortality caused by critical CHD [3]. Diagnosing congenital heart defects relies on clinical evaluation, cardiac imaging and genetic testing. Advancements in CHD disease detection and care have resulted in over 90% of children with CHD surviving to maturity [4]. In addition, CHD is associated with significant complications. Of the newborns with congenital heart defects, studies demonstrated that (23%) were preterm, (49%) were underweight, (47%) were stunting, and (31%) were wasting [5, 6]. The etiology of congenital heart defects is multifactorial, involving genetic, environmental and developmental factors. Strong evidence for the genetic basis of CHD is being found in the disease’s familial forms, high recurrence risk, and well-established link between CHD and chromosomal abnormalities [7, 8]. An estimated 400 genes are linked to the pathophysiology of CHD. CHD mutations in genes encoding transcription factors, cell signaling transducers, and chromatin modifiers can disrupt heart structure and function. These mutations can interfere with cell proliferation, type commitment and differentiation, which are crucial for heart development [9]. JAG1 is a corresponding ligand for the Notch signaling pathway and is expressed from the early stages of heart formation. Together with other components of the Notch signaling pathway, it governs various key steps in embryonic cardiac development [10]. Notch1/JAG1 activation promotes the specification of cardiac progenitors by inhibiting premature differentiation, thereby preserving a pool of undifferentiated cells for subsequent cardiomyogenesis [11, 12]. Mutations in JAG1 are linked to rare autosomal-dominant disorders, often resulting from haploinsufficiency in the Notch signaling pathway, which impacts organ development [13]. While predominantly associated with Alagille syndrome (ALGS), defects in the JAG1 gene can also be found in patients with presumably isolated heart defects, such as tetralogy of Fallot or pulmonic stenosis [14]. The intricate role of JAG1 mutations in congenital heart disease (CHD) pathogenesis underscores the importance of comprehensively understanding their phenotypic implications. Congenital heart disease (CHD) complications extend beyond structural abnormalities. For example, chronic pulmonary overcirculation produced by shunt flow to individuals with an atrial septal defect (ASD) can lead to pulmonary vascular remodeling and increased pulmonary vascular resistance. Such changes may cause atrial arrhythmias, right ventricular dilation, right heart failure, and, most significantly, pulmonary hypertension. Pulmonary hypertension has been observed to develop in 35% of unrepaired ASD patients and is strongly associated with a higher chance of mortality and a predictor of less favorable outcomes following repair [15]. Accurate and detailed reporting of JAG1 related disorders relies on comprehensive clinical evaluation, genetic testing, and multidisciplinary collaboration. Next-generation sequencing techniques facilitate the detection of JAG1 mutations, enabling personalized management strategies. Here, we report a novel mutation in JAG1 that is associated with extreme preterm delivery (Week 25) with an isolated cardiac phenotype, including atrial septal defect II (ASD II), patent ductus arteriosus (PDA) and severe pulmonary hypertension. Materials and methods Genomic DNA isolation Genomic DNA was extracted using the QIAquick DNA extraction kit (QIAamp, Qiagen, Valencia, CA, USA). DNA quantity and quality were assessed using the Nanodrop-2000TM spectrophotometer (Thermo Scientific, Schaumburg, IL, USA). Whole exome sequencing Whole exome sequencing was performed at Eurofins (Biomnis facility, France) for all family members, consisting of two siblings (proband: II:1, Brother: II:2) and both parents (I:1, I:2). From 50 ng of fragmented DNA, indexed libraries were prepared and hybridized with biotinylated probes of Twist Human Core Exome (37 Mb). The samples were prepared following the manufacturer's recommendations. The pools of libraries (multiplexed by 36 samples) were sequenced on the Illumina NextSeq 2000 sequencer in paired-end (2 × 150 bp) on Flow Cell P3. Sequence variant analysis The raw data (file in BCL format) are converted to fastq format using Dragen BCL Convert v.3.7.4 software (Illumina). The sequences were analyzed following the best practices recommended by the GATK Broad Institute, with two pipelines:Internal Pipeline: BWA-MEM, GATK v3.6—44ge7d1cd2SeqOne Pipeline: v 1.2, 2018 Internal Pipeline: BWA-MEM, GATK v3.6—44ge7d1cd2 Internal Pipeline: BWA-MEM, GATK v3.6—44ge7d1cd2 SeqOne Pipeline: v 1.2, 2018 SeqOne Pipeline: v 1.2, 2018 Variants were filtered according to their level of coverage (DP > 10X), their frequency in GnomAD (< 1%), their quality (medium or high), their allelic balance (> 20%), impact on the protein, and transmission. Results Case presentation The proband is a Saudi Arabian female, the daughter of a mother with a history of three miscarriages and six pregnancies. The patient's clinical course is illustrated in Fig. 1. She was born extremely preterm at 25 weeks of gestation via cesarean section, weighing 600 g and measuring 33 cm in length. Immediately after birth, she required intubation and mechanical ventilation and subsequently developed bronchopulmonary dysplasia (BPD). The neonatal course was complicated by pulmonary hypertension (PH), with an initial mean pulmonary artery pressure (mPAP) of 33 mmHg and failure to wean from supplemental oxygen. Early laboratory results showed severe anemia and blood cultures positive for coagulase-negative Staphylococcus. During infancy (birth to 8 months), the patient was started on sildenafil and received antibiotics for neonatal infections.Fig. 1Clinical progression and growth of the proband. a Chronological timeline of clinical milestones, diagnoses, and therapeutic interventions from birth to age 11. b Growth parameters (weight and height). c Hemodynamic progression of pulmonary arterial hypertension, showing a significant increase in right ventricular systolic pressure (RVSP) over time. All this figure parts were created by the authors of this study Clinical progression and growth of the proband. a Chronological timeline of clinical milestones, diagnoses, and therapeutic interventions from birth to age 11. b Growth parameters (weight and height). c Hemodynamic progression of pulmonary arterial hypertension, showing a significant increase in right ventricular systolic pressure (RVSP) over time. All this figure parts were created by the authors of this study At 8 months of age, echocardiography confirmed a large secundum ASD (6–7 mm) and a PDA with bidirectional shunting, leading to a procedural intervention via cardiac catheterization for successful PDA device closure. Echocardiography also revealed suprasystemic right ventricular (RV) systolic pressure of 110 mmHg and right-sided chamber dilation (Fig. 2). In addition, a complete thrombosis of the left common and external iliac arteries was also noted via Doppler ultrasound. Management required an intensive multi-drug regimen, including pulmonary vasodilators (sildenafil, Iloprost), anti-inflammatories (prednisolone, montelukast, fluticasone), and diuretics (furosemide).Fig. 2a Apical four-chamber view of echocardiography showing a large atrial septal defect (*) and dilated right ventricle (RV). RA: right atrium, LA: left atrium, LV: left ventricle. b Lateral angiogram obtained during cardiac catheterization and showing a large patent ductus arteriosus (*). MPA: main pulmonary artery, DAo: descending aorta a Apical four-chamber view of echocardiography showing a large atrial septal defect (*) and dilated right ventricle (RV). RA: right atrium, LA: left atrium, LV: left ventricle. b Lateral angiogram obtained during cardiac catheterization and showing a large patent ductus arteriosus (*). MPA: main pulmonary artery, DAo: descending aorta At age 4, the patient presented to the emergency department with acute respiratory distress and a productive cough. Laboratory investigations revealed a leukoerythroblastic blood picture and respiratory cultures positive for Pseudomonas aeruginosa (> 10,000 cfu/ml). During this period, severe failure to thrive (FTT) was documented at a weight of 10.5 kg, and Nexium was introduced to improve her appetite. By age 11, the patient’s condition progressed to advanced pulmonary hypertension and right heart failure. Echocardiography demonstrated severe tricuspid regurgitation (TR) with a maximum pressure gradient of 100 mmHg and a systemic blood pressure of 120 mmHg (Fig. 3). Key findings included a “D-shaped” left ventricle due to severe interventricular septal shift and reduced RV systolic function. The ASD shunt had transitioned to a predominantly right-to-left direction, consistent with Eisenmenger physiology. A blood smear at this stage showed microcytic hypochromic red blood cells with significant anisopoikilocytosis (pencil cells, spur cells, and burr cells). The therapeutic regimen was escalated to include triple therapy with selexipag, ambrisentan, and sildenafil, alongside spironolactone and furosemide for heart failure management.Fig. 3a Parasternal short-axis view echocardiographic image demonstrating the anatomical relationship between the right ventricle (RV) and left ventricle (LV). The RV is visualized anteriorly, appearing dilated and hypertensive, while the LV is located posteriorly with a thicker myocardial wall and larger cavity. b Color Doppler echocardiography demonstrating tricuspid regurgitation (TR) with continuous-wave Doppler assessment of the regurgitant jet. The Doppler spectrum shows a peak tricuspid regurgitation velocity (TR Vmax) of 5.5 m/s, corresponding to a calculated maximum pressure gradient (Max PG) of 121 mmHg using the modified Bernoulli equation. The dense, high-velocity systolic jet profile is consistent with severely elevated right ventricular systolic pressure, suggestive of significant pulmonary hypertension. The upper panel displays the color Doppler jet across the tricuspid valve, while the lower panel shows the continuous-wave Doppler envelope used for velocity measurement a Parasternal short-axis view echocardiographic image demonstrating the anatomical relationship between the right ventricle (RV) and left ventricle (LV). The RV is visualized anteriorly, appearing dilated and hypertensive, while the LV is located posteriorly with a thicker myocardial wall and larger cavity. b Color Doppler echocardiography demonstrating tricuspid regurgitation (TR) with continuous-wave Doppler assessment of the regurgitant jet. The Doppler spectrum shows a peak tricuspid regurgitation velocity (TR Vmax) of 5.5 m/s, corresponding to a calculated maximum pressure gradient (Max PG) of 121 mmHg using the modified Bernoulli equation. The dense, high-velocity systolic jet profile is consistent with severely elevated right ventricular systolic pressure, suggestive of significant pulmonary hypertension. The upper panel displays the color Doppler jet across the tricuspid valve, while the lower panel shows the continuous-wave Doppler envelope used for velocity measurement Variant identification Exome sequencing of the proband, her parents and brother identified a previously undescribed missense heterozygous variant in the JAG1 gene, p. (Asp376Gly). This mutation is a likely pathogenic variant according to American College of Medical Genetics and Genomics criteria:PP3: multiple lines of computational evidence support a deleterious effect on the gene/gene product (damaging: DANN, FATHMM, FATHMM-MKL, LRT, MetaLR, MetaSVM, Mutation Taster, Provean, SIFT; benign: none). Furthermore, this nucleotide is highly conserved (GERP + + , PhastCons100Way vertebrate, PhyloP100way Vertebrate, SiPhy).PM2: this variant is absent from gnomAD version 4 (1.6 Million chromosomes).Conserved amino acid up to Drosophila melanogaster (Fly).Grantham score 94 on a range from 0 to 215. PP3: multiple lines of computational evidence support a deleterious effect on the gene/gene product (damaging: DANN, FATHMM, FATHMM-MKL, LRT, MetaLR, MetaSVM, Mutation Taster, Provean, SIFT; benign: none). Furthermore, this nucleotide is highly conserved (GERP + + , PhastCons100Way vertebrate, PhyloP100way Vertebrate, SiPhy). PP3: multiple lines of computational evidence support a deleterious effect on the gene/gene product (damaging: DANN, FATHMM, FATHMM-MKL, LRT, MetaLR, MetaSVM, Mutation Taster, Provean, SIFT; benign: none). Furthermore, this nucleotide is highly conserved (GERP + + , PhastCons100Way vertebrate, PhyloP100way Vertebrate, SiPhy). PM2: this variant is absent from gnomAD version 4 (1.6 Million chromosomes). PM2: this variant is absent from gnomAD version 4 (1.6 Million chromosomes). Conserved amino acid up to Drosophila melanogaster (Fly). Conserved amino acid up to Drosophila melanogaster (Fly). Grantham score 94 on a range from 0 to 215. Grantham score 94 on a range from 0 to 215. The presumed healthy mother was found to be a carrier. The older brother and the father are not carriers of this variant (Fig. 4). This mutation was inherited from the presumed healthy mother, which can be explained by incomplete penetrance observed in many JAG1 mutations [16].Fig. 4a Pedigree of the reported case showing carrier status of the mother and the proband. b Jagged-1 domains illustration pointing to the reported mutation in the third epidermal growth factor-like domain (DSL: Delta/Serrate/Lag-2, EGF: epidermal growth factor-like domain, CA: calcium, VWC: Von Willebrand factor type C domain). All this figure parts were created by the authors of this study a Pedigree of the reported case showing carrier status of the mother and the proband. b Jagged-1 domains illustration pointing to the reported mutation in the third epidermal growth factor-like domain (DSL: Delta/Serrate/Lag-2, EGF: epidermal growth factor-like domain, CA: calcium, VWC: Von Willebrand factor type C domain). All this figure parts were created by the authors of this study Conclusion We report a case of a patient who suffered from extreme preterm birth and congenital heart disease. The patient's heart imaging and echocardiography showed a large congenital ASD, PDA and pulmonary hypertension. The patient was admitted frequently as an inpatient and an outpatient. Genetic testing revealed that the patient is heterozygous for a previously undescribed missense mutation in the JAG1 gene. The mutation is the first point mutation in the third epidermal growth factor-like (EGF-3) domain of the JAG1 protein. While most JAG1 mutations cause Alagille syndrome, this case does not involve other organs such as the liver, spine or renal deformation. This single organ involvement proves that a JAG1 mutation phenotype could implicate isolated congenital heart defects (CHD). The mother is presumably healthy carrier of the mutation supporting previously observed variable expressivity and incomplete penetrance of JAG1 mutations. This report underscores the complex clinical presentation and genetic foundations of JAG1 related disorders. In this case report, the identified novel JAG1 variant (c.1127A > G; p.Asp376Gly) likely underlies the patient’s congenital heart disease through haploinsufficiency, a mechanism characterized by significant variable expressivity and incomplete penetrance. The clinical presentation-ranging from isolated cardiac defects to syndromic Alagille syndrome-is frequently influenced by genetic modifiers within the Notch signaling pathway (such as NOTCH2 or JAG2), epigenetic factors that alter allele-specific expression, and environmental stressors like gestational hypoxia. In this specific instance, the patient’s extreme prematurity may have acted as a significant clinical modifier, potentially exacerbating the vascular and respiratory complications associated with the JAG1 mutation. While this case provides significant insight into a novel genotype–phenotype correlation, several limitations must be acknowledged. First, this is a single-case report; as such, the findings may not be generalizable to all individuals carrying variants in the JAG1 gene. Second, while computational evidence and high evolutionary conservation suggest the c.1127A > G (p.Asp376Gly) variant is deleterious, we did not perform functional confirmation (such as in vitro assays) to definitively characterize the mutation's impact on the Notch signaling pathway. Third, although whole exome sequencing was utilized, this method primarily captures protein-coding regions and may overlook deep intronic variants or complex structural rearrangements that could influence the isolated cardiac phenotype observed. Finally, the patient was born extremely preterm (25 weeks), which may have acted as a confounding factor in the severity of the phenotype.